<2> Kenvue Inc. (KVUE) PT Lifted to $19 at Barclays After Q4 Update
<3> Overview of Kenvue Inc.
Kenvue Inc. (KVUE) is a leading consumer healthcare company that has been making waves in the industry with its innovative products and services. Recently, the company announced its Q4 update, which led to a significant boost in its stock price. In this article, we will delve into the details of the update and analyze the impact it has had on the company’s stock price.
<3> Q4 Update and Stock Price Reaction
During the Q4 update, Kenvue Inc. reported a significant increase in revenue, driven by the strong performance of its consumer healthcare business. The company’s revenue growth was fueled by the success of its new product launches, as well as the expansion of its existing product portfolio. As a result, the company’s stock price saw a significant boost, with shares rising by over 10% in a single trading session.
<3> PT Lifted to $19 at Barclays
Following the Q4 update, Barclays, a leading investment bank, lifted its price target for Kenvue Inc. to $19. This represents a significant increase from the previous price